Genus Plc Stock Shares Outstanding

GENSF Stock  USD 20.90  0.00  0.00%   
Genus plc fundamentals help investors to digest information that contributes to Genus Plc's financial success or failures. It also enables traders to predict the movement of Genus Pink Sheet. The fundamental analysis module provides a way to measure Genus Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genus Plc pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Genus plc Company Shares Outstanding Analysis

Genus Plc's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Genus Plc Shares Outstanding

    
  65.77 M  
Most of Genus Plc's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genus plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Genus plc has 65.77 M of shares currently outstending. This is 63.57% lower than that of the Healthcare sector and 38.44% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 88.5% higher than that of the company.

Genus Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genus Plc's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Genus Plc could also be used in its relative valuation, which is a method of valuing Genus Plc by comparing valuation metrics of similar companies.
Genus Plc is currently under evaluation in shares outstanding category among its peers.

Genus Fundamentals

About Genus Plc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Genus plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genus Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genus plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Genus Pink Sheet

Genus Plc financial ratios help investors to determine whether Genus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genus with respect to the benefits of owning Genus Plc security.